☆ 4.6 Letter

Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open-label, extension trial

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Journal

BRITISH JOURNAL OF HAEMATOLOGY

Volume 198, Issue 4, Pages E59-E62

Publisher

WILEY

DOI: 10.1111/bjh.18289

Keywords

-

Categories

Hematology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.